Longevity Health (XAGE) Competitors $2.45 -0.13 (-5.04%) As of 11:52 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsOwnershipSEC FilingsTrendsBuy This Stock XAGE vs. ALUR, NVNO, STSS, NXL, OSRH, IINN, INBS, BTCY, MHUA, and DHAIShould you be buying Longevity Health stock or one of its competitors? The main competitors of Longevity Health include Allurion Technologies (ALUR), enVVeno Medical (NVNO), Sharps Technology (STSS), Nexalin Technology (NXL), OSR (OSRH), Inspira Technologies OXY B.H.N. (IINN), Intelligent Bio Solutions (INBS), Biotricity (BTCY), Meihua International Medical Technologies (MHUA), and DIH Holding US (DHAI). These companies are all part of the "medical equipment" industry. Longevity Health vs. Its Competitors Allurion Technologies enVVeno Medical Sharps Technology Nexalin Technology OSR Inspira Technologies OXY B.H.N. Intelligent Bio Solutions Biotricity Meihua International Medical Technologies DIH Holding US Longevity Health (NASDAQ:XAGE) and Allurion Technologies (NYSE:ALUR) are both small-cap medical equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, media sentiment, earnings, risk, valuation and dividends. Is XAGE or ALUR more profitable? Allurion Technologies has a net margin of -158.30% compared to Longevity Health's net margin of -682.67%. Company Net Margins Return on Equity Return on Assets Longevity Health-682.67% N/A -261.90% Allurion Technologies -158.30%N/A -59.91% Which has more volatility and risk, XAGE or ALUR? Longevity Health has a beta of 0.51, indicating that its share price is 49% less volatile than the S&P 500. Comparatively, Allurion Technologies has a beta of -0.46, indicating that its share price is 146% less volatile than the S&P 500. Do institutionals and insiders have more ownership in XAGE or ALUR? 24.2% of Longevity Health shares are held by institutional investors. Comparatively, 21.4% of Allurion Technologies shares are held by institutional investors. 29.0% of Longevity Health shares are held by insiders. Comparatively, 9.6% of Allurion Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Do analysts prefer XAGE or ALUR? Allurion Technologies has a consensus target price of $22.83, suggesting a potential upside of 987.30%. Given Allurion Technologies' stronger consensus rating and higher probable upside, analysts plainly believe Allurion Technologies is more favorable than Longevity Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Longevity Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Allurion Technologies 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.80 Which has stronger valuation and earnings, XAGE or ALUR? Allurion Technologies has higher revenue and earnings than Longevity Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLongevity Health$1.05M4.15-$10.37MN/AN/AAllurion Technologies$32.11M0.51-$7.20M-$12.53-0.17 Does the media favor XAGE or ALUR? In the previous week, Allurion Technologies had 1 more articles in the media than Longevity Health. MarketBeat recorded 1 mentions for Allurion Technologies and 0 mentions for Longevity Health. Longevity Health's average media sentiment score of 1.88 beat Allurion Technologies' score of 1.00 indicating that Longevity Health is being referred to more favorably in the media. Company Overall Sentiment Longevity Health Very Positive Allurion Technologies Positive SummaryAllurion Technologies beats Longevity Health on 9 of the 14 factors compared between the two stocks. Get Longevity Health News Delivered to You Automatically Sign up to receive the latest news and ratings for XAGE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding XAGE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XAGE vs. The Competition Export to ExcelMetricLongevity HealthSurgical, Medical, And Dental Instruments And Supplies IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$4.37M$170.87M$2.51B$9.82BDividend YieldN/AN/A2.54%4.48%P/E RatioN/A2.4726.4326.53Price / Sales4.152.5998.50108.84Price / CashN/A4.1623.5128.92Price / Book-1.171.5029.126.55Net Income-$10.37M-$66.04M$16.40M$265.93M7 Day Performance-10.26%-5.97%0.06%-0.58%1 Month Performance-13.43%-4.41%3.99%6.25%1 Year PerformanceN/A177.27%28.50%22.32% Longevity Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XAGELongevity HealthN/A$2.45-5.0%N/AN/A$4.37M$1.05M0.0014Positive NewsALURAllurion Technologies2.7282 of 5 stars$2.16-2.7%$22.83+957.1%-87.3%$17.23M$32.11M-0.17501Positive NewsShort Interest ↓Gap UpNVNOenVVeno Medical2.1833 of 5 stars$0.80-8.1%N/A-84.6%$16.75MN/A-0.6730Positive NewsGap UpSTSSSharps Technology0.8846 of 5 stars$13.55-15.5%N/AN/A$16.40M$222.72K-0.013News CoverageShort Interest ↑Gap UpNXLNexalin Technology2.2529 of 5 stars$0.96+4.2%$5.00+422.8%+2.2%$15.99M$174.81K-1.263Short Interest ↑Gap DownOSRHOSRN/A$0.78+4.9%N/AN/A$15.98M$104.74K0.00N/APositive NewsIINNInspira Technologies OXY B.H.N.3.3879 of 5 stars$1.15-2.5%$2.00+73.9%+9.3%$14.89MN/A0.0020Short Interest ↓INBSIntelligent Bio Solutions0.4805 of 5 stars$1.62-1.8%N/A+12.8%$14.82M$3.05M-0.7910Positive NewsBTCYBiotricityN/A$0.54-5.3%N/A+39.7%$13.45M$12.06M-0.5040News CoverageGap UpMHUAMeihua International Medical Technologies1.8102 of 5 stars$0.42+0.5%N/A-54.2%$13.33M$96.91M0.00620Positive NewsShort Interest ↓Gap DownDHAIDIH Holding US1.2628 of 5 stars$0.26-5.8%N/A-88.4%$13.24M$64.47M-0.88N/AShort Interest ↓ Related Companies and Tools Related Companies Allurion Technologies Alternatives enVVeno Medical Alternatives Sharps Technology Alternatives Nexalin Technology Alternatives OSR Alternatives Inspira Technologies OXY B.H.N. Alternatives Intelligent Bio Solutions Alternatives Biotricity Alternatives Meihua International Medical Technologies Alternatives DIH Holding US Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:XAGE) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Longevity Health Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Longevity Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XAGE Stock Alerts